Current progress in the development of prophylactic and therapeutic vaccines
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current progress in the development of prophylactic and therapeutic vaccines
Authors
Keywords
-
Journal
Science China-Life Sciences
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-05
DOI
10.1007/s11427-022-2230-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
- (2022) Chulwoo Kim et al. JOURNAL OF MICROBIOLOGY
- Development of a skin- and neuro-attenuated live vaccine for varicella
- (2022) Wei Wang et al. Nature Communications
- New Approaches to Dendritic Cell-Based Therapeutic Vaccines Against HIV-1 Infection
- (2022) Marisierra Espinar-Buitrago et al. Frontiers in Immunology
- The Efficacy of Therapeutic DNA Vaccines Expressing the Human Papillomavirus E6 and E7 Oncoproteins for Treatment of Cervical Cancer: Systematic Review
- (2022) Ayazhan Akhatova et al. Vaccines
- Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial
- (2022) Gui-Ling Chen et al. Lancet Microbe
- Circular RNA vaccines against SARS-CoV-2 and emerging variants
- (2022) Liang Qu et al. CELL
- Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX—a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine
- (2022) Samantha M. Y. Chen et al. JOURNAL OF VIROLOGY
- Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
- (2022) Akash Khobragade et al. LANCET
- A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26
- (2022) Miao Yu et al. VACCINE
- Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70
- (2022) Ciying Qian et al. npj Vaccines
- Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
- (2021) Philip J.M. Brouwer et al. CELL
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A randomized placebo-controlled efficacy study of a prime boost therapeutic vaccination strategy in HIV-1 infected individuals: VRI02 ANRS 149 LIGHT Phase II trial
- (2021) Y. Lévy et al. JOURNAL OF VIROLOGY
- Novel approaches for vaccine development
- (2021) Makda S. Gebre et al. CELL
- Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer—Results from Phase Ib Trial IMU.ACS.001
- (2021) Ursula Wiedermann et al. CLINICAL CANCER RESEARCH
- A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9
- (2021) Markus Zeitlinger et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Phase I studies of peptide vaccine cocktails derived from GPC3, WDRPUH and NEIL3 for advanced hepatocellular carcinoma
- (2021) Masafumi Ikeda et al. Immunotherapy
- Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
- (2021) Kevin O. Saunders et al. NATURE
- Quadrivalent influenza nanoparticle vaccines induce broad protection
- (2021) Seyhan Boyoglu-Barnum et al. NATURE
- Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
- (2021) Brian J. Ward et al. NATURE MEDICINE
- Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
- (2021) Alexandra C. Walls et al. CELL
- Efficacy and Safety of a Nanoparticle Therapeutic Vaccine in Patients with Chronic Hepatitis B: A Randomized Clinical Trial
- (2021) Lai Wei et al. HEPATOLOGY
- Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy
- (2021) Ying Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potent neutralization of SARS‐CoV ‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
- (2021) Peter J. Halfmann et al. Bioengineering & Translational Medicine
- Current view on novel vaccine technologies to combat human infectious diseases
- (2021) Zrinka Matić et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Therapeutic vaccines for breast cancer: Has the time finally come?
- (2021) Chiara Corti et al. EUROPEAN JOURNAL OF CANCER
- Brief report on a phase I/IIa study to assess the safety, tolerability, and immune response of AGMG0201 in patients with essential hypertension
- (2021) Hironori Nakagami et al. HYPERTENSION RESEARCH
- Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
- (2021) Zhixiong Cai et al. Molecular Cancer
- A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
- (2021) Jonas S. Heitmann et al. NATURE
- Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
- (2021) Lisa M. Dunkle et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
- (2021) M. Gordon Joyce et al. Cell Reports
- Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial
- (2021) Lorna Leal et al. Frontiers in Immunology
- Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)
- (2021) Jakob Trimpert et al. Science Advances
- Functionalizing Ferritin Nanoparticles for Vaccine Development
- (2021) Margarida Q. Rodrigues et al. Pharmaceutics
- Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines
- (2021) Chakkumkal Anish et al. npj Vaccines
- Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
- (2021) Majed Ghattas et al. Vaccines
- Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
- (2021) Peter G Kremsner et al. LANCET INFECTIOUS DISEASES
- HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development
- (2020) Atefeh Arab et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Results of a randomized phase IIb trial of nelipepimut-S + trastuzumab vs trastuzumab to prevent recurrences in high-risk HER2 low-expressing breast cancer patients
- (2020) G. Travis Clifton et al. CLINICAL CANCER RESEARCH
- Peptide vaccine as an adjuvant therapy for glypican‐3 positive hepatocellular carcinoma induces peptide specific CTLs and improves long prognosis
- (2020) Masatake Taniguchi et al. CANCER SCIENCE
- Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
- (2020) Ming Te Yeh et al. Cell Host & Microbe
- Evaluation of safety, immunogenicity, and preliminary efficacy of PolyPEPI1018 off-the-shelf vaccine with fluoropyrimidine/bevacizumab maintenance therapy in metastatic colorectal cancer (mCRC) patients.
- (2020) Joleen Marie Hubbard et al. JOURNAL OF CLINICAL ONCOLOGY
- Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure
- (2020) Hongping Jin et al. Viruses-Basel
- Mechanism of Virus Attenuation by Codon Pair Deoptimization
- (2020) Nicole Groenke et al. Cell Reports
- Recent Progress on the Versatility of Virus-Like Particles
- (2020) Ciying Qian et al. Vaccines
- A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
- (2020) Lianpan Dai et al. CELL
- A Thermostable mRNA Vaccine against COVID-19
- (2020) Na-Na Zhang et al. CELL
- Diabetes mellitus as a vaccine-effect modifier: a review
- (2020) Thomas Verstraeten et al. Expert Review of Vaccines
- Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews
- (2020) Sarwat T Khan et al. BMJ Open
- Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
- (2020) Claire Smalley Rumfield et al. Journal for ImmunoTherapy of Cancer
- 1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 randomised trial
- (2020) G. Giaccone et al. ANNALS OF ONCOLOGY
- mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
- (2020) Gal Cafri et al. JOURNAL OF CLINICAL INVESTIGATION
- A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A
- (2020) Jacopo Enotarpi et al. Nature Communications
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
- (2020) Ligong Lu et al. Science China-Life Sciences
- Combined GS-4774 and Tenofovir Therapy can Improve HBV-Specific T-Cell Responses in Patients with Chronic Hepatitis
- (2019) Carolina Boni et al. GASTROENTEROLOGY
- Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
- (2019) Jessica Marcandalli et al. CELL
- ScanNeo: identifying indel derived neoantigens using RNA-Seq data
- (2019) Ting-You Wang et al. BIOINFORMATICS
- Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension
- (2019) Yong Dai et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Therapeutic efficacy of a human papillomavirus type 16 E7 bacterial exotoxin fusion protein adjuvanted with CpG or GPI-0100 in a preclinical mouse model for HPV-associated disease
- (2019) Diane M. Da Silva et al. VACCINE
- Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients
- (2019) Adam E. Snook et al. Journal for ImmunoTherapy of Cancer
- Next-Generation Cancer Immunotherapy Targeting Glypican-3
- (2019) Yasuhiro Shimizu et al. Frontiers in Oncology
- A proof of concept for structure-based vaccine design targeting RSV in humans
- (2019) Michelle C. Crank et al. SCIENCE
- Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women
- (2019) YueMei Hu et al. Science China-Life Sciences
- Corrigendum: Induction of Robust B Cell Responses After Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells
- (2019) Gustaf Lindgren et al. Frontiers in Immunology
- Real‐world outcomes of sipuleucel‐T treatment in PROCEED, a prospective registry of men with metastatic castration‐resistant prostate cancer
- (2019) Celestia S. Higano et al. CANCER
- The biogenesis, biology and characterization of circular RNAs
- (2019) Lasse S. Kristensen et al. NATURE REVIEWS GENETICS
- 1592TiPATALANTE-1 randomized phase III trial, OSE-2101 versus standard treatment as second or third-line in HLA-A2 positive advanced non-small cell lung cancer (NSCLC) patients
- (2019) E Felip et al. ANNALS OF ONCOLOGY
- A phase 2, prospective, randomized, multicenter, open-label study of GX-188E, an HPV DNA vaccine, in patients with cervical intraepithelial neoplasia 3
- (2019) Youn Jin Choi et al. CLINICAL CANCER RESEARCH
- Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
- (2019) Philip J. M. Brouwer et al. Nature Communications
- Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
- (2019) Amir Abbas Momtazi-Borojeni et al. BMC Medicine
- A bivalent antihypertensive vaccine targeting L‐type calcium channels and angiotensin AT 1 receptors
- (2019) Hailang Wu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Peptide-Based Vaccines: Current Progress and Future Challenges
- (2019) Ryan J. Malonis et al. CHEMICAL REVIEWS
- Vaccine Targeted Alpha 1D-Adrenergic Receptor for Hypertension
- (2019) Chang Li et al. HYPERTENSION
- Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2019) Dereck R. Tait et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection
- (2018) Cynthia L. Gay et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer
- (2018) Raghav Sundar et al. BMC CANCER
- Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association With Overall Survival
- (2018) Emmanuel S. Antonarakis et al. CLINICAL CANCER RESEARCH
- Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
- (2018) Kai Xu et al. NATURE MEDICINE
- Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice
- (2018) Ryo Kawakami et al. PLoS One
- Differential effects of two therapeutic cancer vaccines on short- and long-term survival populations among patients with advanced lung cancer
- (2018) Lizet Sanchez et al. SEMINARS IN ONCOLOGY
- The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease
- (2018) Heeji Lim et al. VACCINE
- Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations
- (2018) Willem M. Kühtreiber et al. npj Vaccines
- Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)
- (2018) Mamun Al Mahtab et al. PLoS One
- Current status of immunotherapy in metastatic colorectal cancer
- (2018) Pawel Wrobel et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer
- (2018) Atsushi Ogura et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- On the mechanisms of conjugate vaccines
- (2018) Rino Rappuoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
- (2018) Zhihai Li et al. Nature Communications
- Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice
- (2018) Whitney R. Baldwin et al. Scientific Reports
- Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein−Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma
- (2017) Hidetoshi Nakagawa et al. GASTROENTEROLOGY
- Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread
- (2017) P. Karayiannis Hepatology International
- RNA sensors of the innate immune system and their detection of pathogens
- (2017) Nanhua Chen et al. IUBMB LIFE
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
- (2017) Frank Liang et al. MOLECULAR THERAPY
- Construction of a novel vaccine by conjugating a B-cell epitope of DPP4 to peptide IA2(5)-P2-1 to significantly control type 1 diabetes in NOD mice
- (2017) Ya Li et al. VACCINE
- Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma
- (2017) Jie Shen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
- (2017) Nobuhiro Tsuchiya et al. OncoImmunology
- Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors
- (2017) Nobuhiro Tsuchiya et al. OncoImmunology
- A Therapeutic Peptide Vaccine Against PCSK9
- (2017) Yajie Pan et al. Scientific Reports
- Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence
- (2016) E. A. Mittendorf et al. ANNALS OF ONCOLOGY
- Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
- (2016) Mark S. Riddle et al. Clinical and Vaccine Immunology
- The development and use of the E75 (HER2 369–377) peptide vaccine
- (2016) Guy T Clifton et al. Future Oncology
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
- (2016) Claudia Cavelti-Weder et al. MOLECULAR THERAPY
- Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children
- (2016) Ally Olotu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Generation of influenza A viruses as live but replication-incompetent virus vaccines
- (2016) L. Si et al. SCIENCE
- 5-fluorouracil toxicity in the treatment of colon cancer associated with the genetic polymorphism 2846 A>G (rs67376798)
- (2016) Itamar González-Perera et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Long-Term Reduction of High Blood Pressure by Angiotensin II DNA Vaccine in Spontaneously Hypertensive RatsNovelty and Significance
- (2015) Hiroshi Koriyama et al. HYPERTENSION
- Development of HIV-1 vaccines based on replication competent Tiantan vaccinia vector in China
- (2015) Ying Liu et al. LANCET
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
- (2015) Himal Lal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine immunotherapy in lung cancer: Clinical experience and future directions
- (2015) Morganna Freeman-Keller et al. PHARMACOLOGY & THERAPEUTICS
- Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study
- (2015) Christoph F.R Hatz et al. VACCINE
- Efficacy and safety of evolocumab in reducing lipids and cardiovascular events
- (2015) B. Jones ANNALS OF CLINICAL BIOCHEMISTRY
- A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
- (2014) S. Alfonso et al. CLINICAL CANCER RESEARCH
- Selective antigen-specific CD4+T-cell, but not CD8+T- or B-cell, tolerance corrupts cancer immunotherapy
- (2014) Adam E. Snook et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody
- (2014) A. M. Hernandez et al. JOURNAL OF IMMUNOLOGY
- Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
- (2013) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: Experiences and findings
- (2013) Dao-Zhen Xu et al. JOURNAL OF HEPATOLOGY
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
- (2013) J. Jardine et al. SCIENCE
- Obesity vaccines
- (2013) Mariana P Monteiro Human Vaccines & Immunotherapeutics
- Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer
- (2012) TORU MASUZAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine
- (2012) Jacob Atsmon et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
- (2012) Thomas Gardner et al. Human Vaccines & Immunotherapeutics
- 1367 RELAPSE AFTER ANALOGUES TREATMENT DISCONTINUATION IS NOT PREVENTED BY DNA VACCINATION IN CHRONIC HEPATITIS B (ANRS HB 02 VAC-ADN)
- (2011) H. Fontaine et al. JOURNAL OF HEPATOLOGY
- Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children
- (2011) Patrick Georges Cech et al. PLoS One
- Role for the Membrane Receptor Guanylyl Cyclase-C in Attention Deficiency and Hyperactive Behavior
- (2011) R. Gong et al. SCIENCE
- Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes
- (2010) Muy-Teck Teh et al. Molecular Cancer
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer
- (2009) Hester van Cruijsen et al. BMC CANCER
- Results of the first phase 1 clinical trial of the HER-2/neupeptide (GP2) vaccine in disease-free breast cancer patients
- (2009) Mark G. Carmichael et al. CANCER
- Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
- (2009) Leisha A. Emens et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Randomized Controlled Trial of an Epidermal Growth Factor Vaccine in Advanced Non–Small-Cell Lung Cancer
- (2008) Elia Neninger Vinageras et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of Immune Responses and Clinical Efficacy in a Phase II Trial of IDM-2101, a 10-Epitope Cytotoxic T-Lymphocyte Vaccine, in Metastatic Non–Small-Cell Lung Cancer
- (2008) Minal Barve et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study
- (2008) Alain C Tissot et al. LANCET
- Engineering attenuated virus vaccines by controlling replication fidelity
- (2008) Marco Vignuzzi et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started